Reuters logo
BRIEF-CLJI worldwide trial enrolls first patient in a study evaluating Viblok
May 23, 2017 / 12:47 PM / 4 months ago

BRIEF-CLJI worldwide trial enrolls first patient in a study evaluating Viblok

May 23 (Reuters) -

* CLJI worldwide trial enrolls first patient in clinical study evaluating the performance of viblok as a barrier for herpes simplex virus transmission in men and women Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below